cadrg-tacpad (Agenda)

Agenda

Times listed are for Eastern Daylight Savings Time.

Download a PDF version of the agenda.

Day 1 (10:50 AM to 5:30 PM)

10:50-11:00 AM

Welcome

Altaf Mohammed, Ph.D., Meeting Co-Organizer, DCP/NCI

Mark Miller, Ph.D., Meeting Co-Organizer, DCP/NCI

11:00-12:00 PM

Plenary Talk

Steven Lipkin, M.D., Ph.D., Weill Cornell Medicine

The CAP-IT Center for LNP RNA Immunoprevention

Session I: Molecularly Targeted Novel Agents and Emerging Technologies for Preventative Agent Development Research
Co-Chairs: Margie Clapper, Ph.D. and John Clifford, Ph.D.
12:00-12:30 PM

Speaker 1: Margie Clapper, Ph.D., Fox Chase Cancer Center

Modulation of Estrogen Metabolism as a Strategy for the Early Interception of Non-Small Cell Lung Cancer

12:30-1:00 PM

Speaker 2: Chinthalapally V. Rao, Ph.D., Oklahoma University Health Sciences Center

Interception of CRC Progression in FAP Rat Model Using a Combinational Targeting of TRAIL Signaling and Inflammation

1:00-1:30 PM

Lunch

1:30-2:00 PM

Speaker 3: Fan Zhang, Ph.D., College of Pharmacy, University of Florida Health

Tuning the Organ-Selectivity of mRNA Expression through Dendrimer-Based Lipid Nanoparticles

2:00-2:30 PM

Speaker 4: Pratip Bhattacharya, Ph.D., MD Anderson Cancer Center

Real-time Hyperpolarized Metabolic Imaging for Early Detection and Prevention of Pancreatic Cancer

2:30-3:00 PM

Speaker 5: Pankaj Singh, Ph.D., OU Health Stephenson Cancer Center
Targeting Metabolic Reprogramming in Pancreatic Cancer

3:00-3:30 PM

Break

3:30-4:30 PM

Early Investigator Flash Talks Co-Chairs: Altaf Mohammed, Ph.D. and Mark Miller, Ph.D.

3:30-3:45 PM

Speaker 1: Atieh Hajirahimkhan, Ph.D., Northwestern University
Reprogramming SREBP1-dependent Lipogenesis and Inflammation in High-Risk Breast with licochalcone A: a Novel Path to Cancer Prevention

3:45-4:00 PM

Speaker 2: Surya Singh, Ph.D., Oklahoma University Health Sciences Center
TRIP13 is a Promising Target for Bladder Cancer Interception

4:00-4:15 PM

Speaker 3: Mariana Bustamante Eduardo, Ph.D., Feinberg School of Medicine
Medium Chain Fatty Acids Shift Metabolism Towards the De Novo Serine Pathway Fostering Epigenetic Plasticity and Oxidative DNA Damage

4:15-4:30 PM

Speaker 4: Tomonori Oka, M.D. Ph.D., Harvard Medical School
Leveraging Epigenetic Regulation of Stemness for Basal Cell Carcinoma Immunoprevention

4:30-5:30 PM

Meet with the NCI Program Staff SessionModerator: Goli Samimi, Ph.D., M.P.H

  • Breakout session I: Agent Development, Vignesh Gunasekharan, Ph.D., and Anda Vlad, M.D., Ph.D.
  • Breakout Session II: Nutritional Sciences, Gabriela Riscuta, M.D., and Amit Kumar, Ph.D.
  • Breakout Session III: Early Detection and Biomarkers, Neeraj Saxena, Ph.D., and Sydney Fu, M.D.

Adjourn 

 

Day 2 Sessions (11:00 AM to 4:00 PM)

Session II: Emerging Vaccines and Immunomodulatory Agents for Cancer Prevention
Co-Chairs: Catherine J. Wu, M.D. and Shizuko Sei, M.D.
11:00-11:30 AM

Speaker 1: Catherine J. Wu, M.D., Dana Farber Cancer Institute

Updates on Personalized Cancer Vaccines


 
11:30-12:00 PM

Speaker 2: Madhav Dhodapkar, M.B.S.S, Emory University

Targeting Underlying Triggers and Spatial Immunology Towards Cancer Prevention

12:00-12:30 PM

Speaker 3: Vinod P. Balachandran, M.D., Memorial Sloan Kettering Cancer Center

Personalized RNA Vaccines for Pancreatic Cancer

12:30-1:00 PM

Speaker 4: Steven Reed, Ph.D., HDTBio

RNA Vaccines for Cancer: Overcoming Challenges

1:00-1:30 PM

Speaker 5: Barbara Vanderhyden, Ph.D., University of Ottawa

Targeting Age-Associated Ovarian Fibrosis to Reduce Cancer Risk

1:30-2:00 PM Lunch
Session III: NCI Resources Session
Co-Chair: Mark Miller, Ph.D.
2:00-2:30 PM

Altaf Mohammed, Ph.D., Program Director, DCP/NCI

CIP-Net Cooperative Grant Program

2:30-3:00 PM

Vignesh Gunasekharan, Ph.D., Deputy Director of PREVENT Operations, DCP/NCI

PREVENT Agent Development Pipeline

3:00-4:00 PM

Meet the Expert Session: 

  • Margie Clapper, Ph.D., Fox Chase Cancer Center
  • Neeha Zaidi, M.D., Johns Hopkins University
Adjourn

 

Day 3 Session (11:00 AM to 2:30 PM)

Session IV: Navigating Prevention Trials: Challenges and Opportunities
Co-Chairs: Ajay Bansal, M.D. and Howard Parnes, M.D.
11:00-11:30 AM

Speaker 1: Eva Szabo, M.D., DCP/NCI

Overview of DCP Supported Clinical Trials


 
11:30-12:00 PM

Speaker 2: Shadmehr Demehri, M.D., Ph.D., Massachusetts General Hospital

Topical Immunotherapy for Skin Cancer Prevention in Organ Transplant Recipients

12:00-12:30 PM

Speaker 3: Ajay Bansal, M.D., University of Kansas

Multivalent Vaccines boosted by IL-15 Superagonist for Cancer Interception in Lynch Syndrome: A Phase IIb Trial

12:30-1:00 PM

Lunch

1:00-1:30 PM

Speaker 4: Julie Bauman, M.D., M.P.H., George Washington University Cancer Center

Green Chemoprevention of Environmental Carcinogenesis: Lessons From The Field

1:30-2:00 PM

Speaker 5: Adetunji T. Toriola, M.D., Ph.D., MPH, University of Washington at St. Louis

Targeting RANKL Signaling in Premenopausal Women with Dense Breasts

2:00-2:30 PM

Speaker 6: Peter Allen, M.D., Duke University

Progress Report on the Prevention of Progression to Pancreatic Cancer (3P-C) Trial

Closing Remarks and Adjourn

Altaf Mohammed, Ph.D., Meeting Co-Organizer, DCP/NCI

Mark Miller, Ph.D., Meeting Co-Organizer, DCP/NCI